This report is being filed on an international product, architect syphilis tp, list 8d06-77, that has a similar product distributed in the us, list number 8d06-31 and 8d06-41.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Patient information: no specific patient information was provided.
|
The investigation of the customer's issue included review of complaint activity, trending data, labeling, device history records and the complaint text.Additionally, in house testing of a retained kit and return sample analysis were completed.Trending report review for the architect syphilis tp assay did not identify any trends.Device history record review for the complaint lot did not identify any non-conformances or deviations for the complaint issue.Labeling was reviewed and sufficiently addresses the complaint issue.The returned specimen sample h224 was tested with an alternate reagent lot of architect syphilis tp.The sample generated a non-reactive result of 0.06 s/co.Although there is no reference test method for the syphilis assay, the sample was also tested on recomline treponema igm, recomline treponema igg methods which also generated negative results.Additionally, in-house testing of a retained kit of lot 25445be00 (which contains the same bulk material as 25445be01) was performed.All controls met specifications and no false non-reactive results were obtained, showing that the lot generates the expected results.Based on this investigation, no systemic issue or deficiency of the architect syphilis reagent lot was identified.
|